Skin cancer in Europe today and challenges for tomorrow

One in every three cancers diagnosed is a skin cancer. Europe has the global lead in the number of UV-attributable cancer cases with the highest number of melanoma cases worldwide and the second highest number of keratinocyte cancers (KC). Further increases are expected in Europe for the coming decades. Projected increases are highest for KC with increases in incidence around 40% and increases in mortality around 50%, with KC mortality in males approximating melanoma mortality in females. The two main drivers for this skin cancer epidemic are ageing of the population but especially UV exposure. In conclusion, skin cancer represents a major challenge in the cancer field in Europe today and will continue to do so in the coming decades. This calls for a European skin cancer action plan intended to reduce avoidable UV exposure and to prepare the healthcare system to safeguard early diagnosis and treatment of skin cancer.

Authors

Institutions

Publication Details

Journal
Journal of the European Academy of Dermatology and Venereology
Published
2024-10-08
DOI
https://doi.org/10.1111/jdv.20368
Citations
23
Primary Topic
Nonmelanoma Skin Cancer Studies
Type
article
Field-Weighted Citation Impact
8.89
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Skin cancer in Europe today and challenges for tomorrow

Claus Garbe, Rüdiger Greinert, Isabelle Hoorens, David C. Whiteman et al.
23 citations
Journal of the European Academy of Dermatology and Venereology
Nonmelanoma Skin Cancer Studies
8.89
article

Skin cancer in Europe today and challenges for tomorrow

Claus Garbe, Rüdiger Greinert, Isabelle Hoorens, David C. Whiteman, Liève Brochez, Joachim Schüz, Brigitta Boonen, Philippe Autier, Beate Volkmer, Martin Röcken
article en
23 citations

Abstract

One in every three cancers diagnosed is a skin cancer. Europe has the global lead in the number of UV-attributable cancer cases with the highest number of melanoma cases worldwide and the second highest number of keratinocyte cancers (KC). Further increases are expected in Europe for the coming decades. Projected increases are highest for KC with increases in incidence around 40% and increases in mortality around 50%, with KC mortality in males approximating melanoma mortality in females. The two main drivers for this skin cancer epidemic are ageing of the population but especially UV exposure. In conclusion, skin cancer represents a major challenge in the cancer field in Europe today and will continue to do so in the coming decades. This calls for a European skin cancer action plan intended to reduce avoidable UV exposure and to prepare the healthcare system to safeguard early diagnosis and treatment of skin cancer.

Journal of the European Academy of Dermatology and VenereologyVol. 39(2)
QIMR Berghofer Medical Research Institute (AU), Ghent University Hospital (BE), International Prevention Research Institute (FR), Cancer Research Institute Ghent (BE), University Children's Hospital Tübingen (DE), Elbe Kliniken Stade-Buxtehude (DE), Centre international de recherche sur le cancer (FR)
Good health and well-being
Openalex Percentile: Top 2%
Nonmelanoma Skin Cancer Studies
8.89
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.